Navigation Links
Unilife Corporation Announces Financial Results For Fiscal Year 2013 Second Quarter
Date:2/11/2013

able auto-injectors were supplied to a number of pharmaceutical companies for evaluation and user studies. Unilife has been advised that these evaluations are progressing favorably.
  • The Unilife EZMix™ drug reconstitution system was selected by a pharmaceutical company for use with a late-stage pipeline drug. Negotiations for an EZMix supply contract with this company are underway.
  • Unilife expanded its commercial development team with the appointment of Douglas Stout, Derek Giersch, Joseph Crusco as Senior Directors of Commercial Development; and Jashin Gugnani as Director of Commercial Development in October 2012; as well as the appointment of Glenn Thorpe as Vice-President of Commercial Development in February 2013.
  • "During the quarter, we were pleased to provide shareholders with greater insight into the size and scope of our commercial pipeline," stated Mr. Alan Shortall, CEO of Unilife. "Out of 31 active programs selected from our deep and rapidly expanding commercial pipeline, we expect several to generate initial revenues during calendar year 2013.  Given the size and long-term nature of many of these prospective agreements, we are confident they will underpin our future success.

    "Over the last few weeks, we raised approximately $13.4 million in net equity capital, which has strengthened our balance sheet as we look to finalize several commercial supply contracts and clinical development agreements.  We are also working to conclude discussions with U.S. institutions to secure long-term debt financing that will support the Company's operational activities and minimize dilution for the foreseeable future," Mr. Shortall concluded.

    Financial Results for Three Months Ended December 31, 2012
    Revenues for the three months ended December 31, 2012, were $0.7 million compared to $0.9 million for the same period in 2011. The Company's net loss for the three months ended December 31, 2012, was $14.6 million, o
    '/>"/>

    SOURCE Unilife Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Unilife Signs Long-Term Supply Contract for the Unifill Prefilled Syringe
    2. Unilife Granted Key U.S. Patent for Unifill Prefilled Syringe
    3. Unilife Corporation to Announce Financial Results for Fiscal 2012 Fourth Quarter and Year End on Monday, July 30, 2012
    4. Unilife Corporation Announces Financial Results For Fiscal Year 2012 Fourth Quarter
    5. Griffin Securities Analyst Interviews Unilife Corp. CEO in a Two-Part Video Series
    6. Unilife Corporation To Announce Financial Results For Fiscal 2013 First Quarter On Tuesday, October 30, 2012
    7. Second Part of the Griffin Securities Analyst Interview with Unilife Corp. CEO is Now Available
    8. Unilife Corporation Reschedules Release Of Quarterly Results And Earnings Call Due To Severe Weather In Northeastern U.S.
    9. Unilifes Bolus Injector Platform Targeted by Global Pharmaceutical Company for Use in Multi-Drug Program
    10. Unilife Corporation Announces Financial Results For Fiscal Year 2013 First Quarter
    11. Unilife to Present at the Lazard 9th Annual Healthcare Conference in New York City on November 13th
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/23/2014)... , Nov. 23, 2014 Anthera Pharmaceuticals, ... Paul F. Truex , President and Chief Executive ... Annual Piper Jaffray Healthcare Conference. Anthera ... at the Palace Hotel in New York ... Anthera Pharmaceuticals is a biopharmaceutical company focused ...
    (Date:11/22/2014)... -- Sprout Pharmaceuticals today announced positive preliminary results from a Phase ... up to 200 mg at bedtime had no next-day impairment ... th Annual Fall Scientific Meeting of the Sexual Medicine ... Miami . The Phase 1 driving ... and the Formal Dispute Resolution that was filed in December ...
    (Date:11/22/2014)... Nov. 21, 2014  CytoSorbents Corporation (OTCQB: CTSO), ... Union approved CytoSorb® cytokine adsorber to treat critically-ill ... Beacon of Light Award at last night,s New ... Dr. Phillip Chan , Chief Executive ... to be recognized by the New Jersey Tech ...
    Breaking Medicine Technology:Anthera Pharmaceuticals to Present at Annual Piper Jaffray Healthcare Conference 2Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment 2Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment 3CytoSorbents Wins Beacon of Light Award 2CytoSorbents Wins Beacon of Light Award 3CytoSorbents Wins Beacon of Light Award 4
    ... 29, 2011 Breast cancer patients and their families ... (FDA) decision to remove the anti-cancer drug Avastin from ... breast cancer. Terry Kalley, founder of the ... the decision, saying, "While this vote is disappointing, it ...
    ... Mass., June 29, 2011 NxStage® Medical, Inc. (Nasdaq: ... dialysis products, announced that it has entered into a ... move its corporate headquarters to the revitalized historic mill ... Street, Lawrence, MA.  The move, which is expected to ...
    Cached Medicine Technology:Breast Cancer Patients and Families Decry FDA Panel Vote to Remove Life Saving Drug From Approved List 2NxStage® Enters Into New Lease for Corporate Headquarters Within Lawrence, MA 2
    (Date:11/26/2014)... 25, 2014 (HealthDay News) -- Exposure to peanut protein ... allergy in infants with the skin condition eczema, a ... children in the United States are allergic to peanuts. ... food allergies, particularly peanut allergy, the researchers noted. ... to 15 months. The researchers examined the amount of ...
    (Date:11/24/2014)... From embedded sensors and biometrics to elite ... will take center stage at the FitnessTech Summit , ... 2015 International CES® , January 6, 2015 in Las ... 2004). The bond between fitness and technology is stronger than ... and more about the human body. , “Fitness technology has ...
    (Date:11/24/2014)... Abington, PA (PRWEB) November 24, 2014 ... Nataliya Ternopolska, MD has joined The Neurology ... Abington Health’s Multiple Sclerosis Center. , A graduate ... residency in Neurology at Albert Einstein Medical Center in ... the Judith Jaffe Multiple Sclerosis Center at Weill Cornell ...
    (Date:11/24/2014)... 24, 2014 The Holiday Inn Westbury ... Family and Children's Association to donate various items ... mouthwash and other such items.The Association's program is aimed ... bound, living in nursing homes, assisted living facilities and ... the well being of seniors throughout the Long Island ...
    (Date:11/24/2014)... (PRWEB) November 24, 2014 ReAdmission ... and disease management services to health plans, hospitals, ... Essette’s Medical Management software suite. ReAdmission Solutions ... in a program to reduce patients' avoidable readmissions ... Health Management, Care Management, Utilization Management, and Appeals ...
    Breaking Medicine News(10 mins):Health News:Infants With Eczema May Be More Prone to Peanut Allergy: Study 2Health News:Next Wave Fitness Products Debut at FitnessTech Summit Living in Digital Times at the 2015 International CES 2Health News:Next Wave Fitness Products Debut at FitnessTech Summit Living in Digital Times at the 2015 International CES 3Health News:Next Wave Fitness Products Debut at FitnessTech Summit Living in Digital Times at the 2015 International CES 4Health News:Nataliya Ternopolska Named Associate Medical Director of Abington Health’s Multiple Sclerosis Center 2Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 2Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 3Health News:ReAdmission Solutions, LLC Selects Essette 2
    ... AIGISRx DEB is designed to reduce the severity of capsular ... ... capsule formation, MONMOUTH ... the commercialization of implantable medical-pharmaceutical,devices, announced today acceptance for presentation ...
    ... -- China Medical,Technologies, Inc. (the "Company") (Nasdaq: CMED ), a leading China-based,medical ... intensity focused ultrasound tumor,therapy systems, today announced the following investor events: Event ... ... Location UBS China Life ...
    ... critically needed supplies to ... clinics, fire and rescue in affected areas, SANTA ... emergency medical supplies to safety-net,clinics and has extended offers ... fires have forced 500,000 people to,evacuate their homes. ...
    ... Inc announced today that its,La Jolla campus will close ... to cope with San Diego County,s ongoing fire,emergency. Determination ... from the many agencies involved in dealing with the,disaster. ... by the fires so it,s,important that they take the ...
    ... Research and,Manufacturers of America (PhRMA) President and CEO ... wildfires: "Californians who have been affected by ... underinsured -- should know that help getting the,medicines ... for,Prescription Assistance. The PPA, sponsored by America,s pharmaceutical,research ...
    ... Department of,Veterans Affairs (VA) continues to offer medical care ... across parts of Southern,California., "We are grateful no ... Secretary of Veterans Affairs Gordon H. Mansfield.,"Our first priority ... The San Diego VA Medical Center and clinics remain ...
    Cached Medicine News:Health News:TyRx Pharma, Inc. Announces Presentation of Results to Benefit Women with Breast Implants (In-Vivo Efficacy Study Regarding AIGISRx DEB) at the Plastic Surgery 2007 Meeting on October, 28 2007 in Baltimore, MD 2Health News:TyRx Pharma, Inc. Announces Presentation of Results to Benefit Women with Breast Implants (In-Vivo Efficacy Study Regarding AIGISRx DEB) at the Plastic Surgery 2007 Meeting on October, 28 2007 in Baltimore, MD 3Health News:China Medical Technologies to Participate in Investor Events in November 2Health News:Direct Relief International Aims California Fire Response at Health Concerns 2Health News:Help for California Fire Evacuees Possible Through Partnership for Prescription Assistance 2
    Ferris Smith Rongeurs, 12 overall length 300 mm....
    It is designed for rigid skeletal fixation. These pins are constructed of stainless steel and can be removed for sterilization and reuse....
    It is designed for rigid skeletal fixation. These pins are constructed of stainless steel and can be removed for sterilization and reuse....
    ... It is designed for ... the surgeon greater freedom in ... 3-point rigid skeletal fixation is ... lateral, or sitting positions. Craniotomies ...
    Medicine Products: